You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Research Letters Efficacy and Safety of Chaperonin 10 in Patients With Moderate to Severe Plaque Psoriasis: Evidence of Utility Beyond a Single Indication
Bronwyn Williams; Daina Vanags; Stephen Hall; Chris McCormack; Peter Foley; Julissa Weiss; Barbara Johnson; Eicke Latz; Dennis Feeney
Arch Dermatol 2008; 144: 683-685.
[Extract][Full text][PDF]
Correspondence Classic Mediterranean Kaposis Sarcoma Regression With Sirolimus Treatment
Emmanuella Guenova; Gisela Metzler; Wolfram Hoetzenecker; Mark Berneburg; Martin Rocken
Arch Dermatol 2008; 144: 692-693.
[Extract][Full text][PDF]
The Cutting Edge Successful Treatment With Etanercept of von Zumbusch Pustular Psoriasis in a Patient With Human Immunodeficiency Virus
Maryann Mikhail; Jeffrey M. Weinberg; Barry L. Smith
Arch Dermatol 2008; 144: 453-456.
[Extract][Full text][PDF]
Observations Suppression of Melanoma-Associated Neoangiogenesis by Bevacizumab
Gesine B. Jaissle; Anja Ulmer; Sigrid Henke-Fahle; Gerhard Fierlbeck; Karl Ulrich Bartz-Schmidt; Peter Szurman
Arch Dermatol 2008; 144: 525-527.
[Abstract][Full text][PDF]
Correspondence Rapid Enlargement of a Malignant Melanoma in a Child With Vitiligo Vulgaris After Application of Topical Tacrolimus
Maryann Mikhail; Jedd Wolchok; Stacie M. Goldberg; Ira J. Dunkel; Daniel F. Roses; Nanette B. Silverberg
Arch Dermatol 2008; 144: 560-561.
[Extract][Full text][PDF]
Observations Bullous Sweet Syndrome in a Patient With t(9;22)(q34;q11)-Positive Chronic Myeloid Leukemia Treated With the Tyrosine Kinase Inhibitor Nilotinib: Interphase Cytogenetic Detection of BCR-ABL– Positive Lesional Cells
Kjell Matthias Kaune; Mario Baumgart; Stefan Gesk; Christina Mitteldorf; Joerg Baesecke; Bertram Glass; Detlef Haase; Reiner Siebert; B. Michael Ghadimi; Christine Neumann; Steffen Emmert
Arch Dermatol 2008; 144: 361-364.
[Abstract][Full text][PDF]
Commentaries Time to Nip "Seeding Trials" in the Bud